Canaccord Genuity Group Lowers Privia Health Group (NASDAQ:PRVA) Price Target to $37.00
Privia Health Group (NASDAQ:PRVA – Free Report) had its price target decreased by Canaccord Genuity Group from $41.00 to $37.00 in a research report report published on Tuesday morning, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also issued reports on PRVA. Truist Financial lowered […]